The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Enterovirus Vaccine Market Research Report 2025
Synopsis
Hand, foot and mouth disease (HFMD) was first reported in New Zealand in 1957 and occurs mostly in young children, with a peak incidence at about 2 years of age. The causative agents of HFMD are picornaviruses, most often of human enterovirus species A, chiefly the Coxsackie A viruses and Enterovirus A71 (EV71). To date three vaccines against EV71 have been licensed in China, all using C4 genogroup strains. The efficacy of these three vaccines after two doses immunization ranges from 90.0% to 97.4% after one year of surveillance to 95.1% after two-year follow-up. Candidate vaccines containing B4 and B5 genogroups are in development elsewhere but have not yet reached the licensing stage. Other vaccines such as recombinant and other forms of subunit vaccines, vectored vaccines, virus-like particle vaccines are in the early stage of development. In addition, the development of vaccines against Coxsackie A16, A6 and A10 is being considered with a view to developing combination/multivalent vaccines
The global Enterovirus Vaccine market was valued at US$ 326 million in 2023 and is anticipated to reach US$ 482.5 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Enterovirus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enterovirus Vaccine.
Report Scope
The Enterovirus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Enterovirus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enterovirus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sinovac Biotech
Medigen Vaccine Biologics
Shenzhen Neptunus
Sinopharm
Adimmune
Intravacc
Shanghai Zerun Biotechnology
Beijing Minhai Biotechnology
Segment by Type
Coxasckievirus A
Coxasckievirus B
Human Enterovirus 71
Others
Segment by Application
Hospital
Research Institute
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Enterovirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Enterovirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Hand, foot and mouth disease (HFMD) was first reported in New Zealand in 1957 and occurs mostly in young children, with a peak incidence at about 2 years of age. The causative agents of HFMD are picornaviruses, most often of human enterovirus species A, chiefly the Coxsackie A viruses and Enterovirus A71 (EV71). To date three vaccines against EV71 have been licensed in China, all using C4 genogroup strains. The efficacy of these three vaccines after two doses immunization ranges from 90.0% to 97.4% after one year of surveillance to 95.1% after two-year follow-up. Candidate vaccines containing B4 and B5 genogroups are in development elsewhere but have not yet reached the licensing stage. Other vaccines such as recombinant and other forms of subunit vaccines, vectored vaccines, virus-like particle vaccines are in the early stage of development. In addition, the development of vaccines against Coxsackie A16, A6 and A10 is being considered with a view to developing combination/multivalent vaccines
The global Enterovirus Vaccine market was valued at US$ 326 million in 2023 and is anticipated to reach US$ 482.5 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Enterovirus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enterovirus Vaccine.
Report Scope
The Enterovirus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Enterovirus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enterovirus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sinovac Biotech
Medigen Vaccine Biologics
Shenzhen Neptunus
Sinopharm
Adimmune
Intravacc
Shanghai Zerun Biotechnology
Beijing Minhai Biotechnology
Segment by Type
Coxasckievirus A
Coxasckievirus B
Human Enterovirus 71
Others
Segment by Application
Hospital
Research Institute
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Enterovirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Enterovirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Enterovirus Vaccine Market Overview
1.1 Product Overview and Scope of Enterovirus Vaccine
1.2 Enterovirus Vaccine Segment by Type
1.2.1 Global Enterovirus Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Coxasckievirus A
1.2.3 Coxasckievirus B
1.2.4 Human Enterovirus 71
1.2.5 Others
1.3 Enterovirus Vaccine Segment by Application
1.3.1 Global Enterovirus Vaccine Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Research Institute
1.3.4 Others
1.4 Global Enterovirus Vaccine Market Size Estimates and Forecasts
1.4.1 Global Enterovirus Vaccine Revenue 2019-2030
1.4.2 Global Enterovirus Vaccine Sales 2019-2030
1.4.3 Global Enterovirus Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Enterovirus Vaccine Market Competition by Manufacturers
2.1 Global Enterovirus Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Enterovirus Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Enterovirus Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Enterovirus Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Enterovirus Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Enterovirus Vaccine, Product Type & Application
2.7 Enterovirus Vaccine Market Competitive Situation and Trends
2.7.1 Enterovirus Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Enterovirus Vaccine Players Market Share by Revenue
2.7.3 Global Enterovirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Enterovirus Vaccine Retrospective Market Scenario by Region
3.1 Global Enterovirus Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Enterovirus Vaccine Global Enterovirus Vaccine Sales by Region: 2019-2030
3.2.1 Global Enterovirus Vaccine Sales by Region: 2019-2024
3.2.2 Global Enterovirus Vaccine Sales by Region: 2025-2030
3.3 Global Enterovirus Vaccine Global Enterovirus Vaccine Revenue by Region: 2019-2030
3.3.1 Global Enterovirus Vaccine Revenue by Region: 2019-2024
3.3.2 Global Enterovirus Vaccine Revenue by Region: 2025-2030
3.4 North America Enterovirus Vaccine Market Facts & Figures by Country
3.4.1 North America Enterovirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Enterovirus Vaccine Sales by Country (2019-2030)
3.4.3 North America Enterovirus Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Enterovirus Vaccine Market Facts & Figures by Country
3.5.1 Europe Enterovirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Enterovirus Vaccine Sales by Country (2019-2030)
3.5.3 Europe Enterovirus Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Enterovirus Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Enterovirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Enterovirus Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Enterovirus Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Enterovirus Vaccine Market Facts & Figures by Country
3.7.1 Latin America Enterovirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Enterovirus Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Enterovirus Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Enterovirus Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Enterovirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Enterovirus Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Enterovirus Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Enterovirus Vaccine Sales by Type (2019-2030)
4.1.1 Global Enterovirus Vaccine Sales by Type (2019-2024)
4.1.2 Global Enterovirus Vaccine Sales by Type (2025-2030)
4.1.3 Global Enterovirus Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Enterovirus Vaccine Revenue by Type (2019-2030)
4.2.1 Global Enterovirus Vaccine Revenue by Type (2019-2024)
4.2.2 Global Enterovirus Vaccine Revenue by Type (2025-2030)
4.2.3 Global Enterovirus Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Enterovirus Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Enterovirus Vaccine Sales by Application (2019-2030)
5.1.1 Global Enterovirus Vaccine Sales by Application (2019-2024)
5.1.2 Global Enterovirus Vaccine Sales by Application (2025-2030)
5.1.3 Global Enterovirus Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Enterovirus Vaccine Revenue by Application (2019-2030)
5.2.1 Global Enterovirus Vaccine Revenue by Application (2019-2024)
5.2.2 Global Enterovirus Vaccine Revenue by Application (2025-2030)
5.2.3 Global Enterovirus Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Enterovirus Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sinovac Biotech
6.1.1 Sinovac Biotech Corporation Information
6.1.2 Sinovac Biotech Description and Business Overview
6.1.3 Sinovac Biotech Enterovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sinovac Biotech Enterovirus Vaccine Product Portfolio
6.1.5 Sinovac Biotech Recent Developments/Updates
6.2 Medigen Vaccine Biologics
6.2.1 Medigen Vaccine Biologics Corporation Information
6.2.2 Medigen Vaccine Biologics Description and Business Overview
6.2.3 Medigen Vaccine Biologics Enterovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medigen Vaccine Biologics Enterovirus Vaccine Product Portfolio
6.2.5 Medigen Vaccine Biologics Recent Developments/Updates
6.3 Shenzhen Neptunus
6.3.1 Shenzhen Neptunus Corporation Information
6.3.2 Shenzhen Neptunus Description and Business Overview
6.3.3 Shenzhen Neptunus Enterovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Shenzhen Neptunus Enterovirus Vaccine Product Portfolio
6.3.5 Shenzhen Neptunus Recent Developments/Updates
6.4 Sinopharm
6.4.1 Sinopharm Corporation Information
6.4.2 Sinopharm Description and Business Overview
6.4.3 Sinopharm Enterovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sinopharm Enterovirus Vaccine Product Portfolio
6.4.5 Sinopharm Recent Developments/Updates
6.5 Adimmune
6.5.1 Adimmune Corporation Information
6.5.2 Adimmune Description and Business Overview
6.5.3 Adimmune Enterovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Adimmune Enterovirus Vaccine Product Portfolio
6.5.5 Adimmune Recent Developments/Updates
6.6 Intravacc
6.6.1 Intravacc Corporation Information
6.6.2 Intravacc Description and Business Overview
6.6.3 Intravacc Enterovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Intravacc Enterovirus Vaccine Product Portfolio
6.6.5 Intravacc Recent Developments/Updates
6.7 Shanghai Zerun Biotechnology
6.6.1 Shanghai Zerun Biotechnology Corporation Information
6.6.2 Shanghai Zerun Biotechnology Description and Business Overview
6.6.3 Shanghai Zerun Biotechnology Enterovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shanghai Zerun Biotechnology Enterovirus Vaccine Product Portfolio
6.7.5 Shanghai Zerun Biotechnology Recent Developments/Updates
6.8 Beijing Minhai Biotechnology
6.8.1 Beijing Minhai Biotechnology Corporation Information
6.8.2 Beijing Minhai Biotechnology Description and Business Overview
6.8.3 Beijing Minhai Biotechnology Enterovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Beijing Minhai Biotechnology Enterovirus Vaccine Product Portfolio
6.8.5 Beijing Minhai Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Enterovirus Vaccine Industry Chain Analysis
7.2 Enterovirus Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Enterovirus Vaccine Production Mode & Process
7.4 Enterovirus Vaccine Sales and Marketing
7.4.1 Enterovirus Vaccine Sales Channels
7.4.2 Enterovirus Vaccine Distributors
7.5 Enterovirus Vaccine Customers
8 Enterovirus Vaccine Market Dynamics
8.1 Enterovirus Vaccine Industry Trends
8.2 Enterovirus Vaccine Market Drivers
8.3 Enterovirus Vaccine Market Challenges
8.4 Enterovirus Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Enterovirus Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Enterovirus Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Enterovirus Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Enterovirus Vaccine Sales (K Doses) of Key Manufacturers (2019-2024)
Table 5. Global Enterovirus Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Enterovirus Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Enterovirus Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Enterovirus Vaccine Average Price (US$/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Enterovirus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Enterovirus Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Enterovirus Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Enterovirus Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Enterovirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enterovirus Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Enterovirus Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Enterovirus Vaccine Sales by Region (2019-2024) & (K Doses)
Table 18. Global Enterovirus Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Enterovirus Vaccine Sales by Region (2025-2030) & (K Doses)
Table 20. Global Enterovirus Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Enterovirus Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Enterovirus Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Enterovirus Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Enterovirus Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Enterovirus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Enterovirus Vaccine Sales by Country (2019-2024) & (K Doses)
Table 27. North America Enterovirus Vaccine Sales by Country (2025-2030) & (K Doses)
Table 28. North America Enterovirus Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Enterovirus Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Enterovirus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Enterovirus Vaccine Sales by Country (2019-2024) & (K Doses)
Table 32. Europe Enterovirus Vaccine Sales by Country (2025-2030) & (K Doses)
Table 33. Europe Enterovirus Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Enterovirus Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Enterovirus Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Enterovirus Vaccine Sales by Region (2019-2024) & (K Doses)
Table 37. Asia Pacific Enterovirus Vaccine Sales by Region (2025-2030) & (K Doses)
Table 38. Asia Pacific Enterovirus Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Enterovirus Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Enterovirus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Enterovirus Vaccine Sales by Country (2019-2024) & (K Doses)
Table 42. Latin America Enterovirus Vaccine Sales by Country (2025-2030) & (K Doses)
Table 43. Latin America Enterovirus Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Enterovirus Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Enterovirus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Enterovirus Vaccine Sales by Country (2019-2024) & (K Doses)
Table 47. Middle East & Africa Enterovirus Vaccine Sales by Country (2025-2030) & (K Doses)
Table 48. Middle East & Africa Enterovirus Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Enterovirus Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Enterovirus Vaccine Sales (K Doses) by Type (2019-2024)
Table 51. Global Enterovirus Vaccine Sales (K Doses) by Type (2025-2030)
Table 52. Global Enterovirus Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Enterovirus Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Enterovirus Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Enterovirus Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Enterovirus Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Enterovirus Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Enterovirus Vaccine Price (US$/Dose) by Type (2019-2024)
Table 59. Global Enterovirus Vaccine Price (US$/Dose) by Type (2025-2030)
Table 60. Global Enterovirus Vaccine Sales (K Doses) by Application (2019-2024)
Table 61. Global Enterovirus Vaccine Sales (K Doses) by Application (2025-2030)
Table 62. Global Enterovirus Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Enterovirus Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Enterovirus Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Enterovirus Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Enterovirus Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Enterovirus Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Enterovirus Vaccine Price (US$/Dose) by Application (2019-2024)
Table 69. Global Enterovirus Vaccine Price (US$/Dose) by Application (2025-2030)
Table 70. Sinovac Biotech Corporation Information
Table 71. Sinovac Biotech Description and Business Overview
Table 72. Sinovac Biotech Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 73. Sinovac Biotech Enterovirus Vaccine Product
Table 74. Sinovac Biotech Recent Developments/Updates
Table 75. Medigen Vaccine Biologics Corporation Information
Table 76. Medigen Vaccine Biologics Description and Business Overview
Table 77. Medigen Vaccine Biologics Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 78. Medigen Vaccine Biologics Enterovirus Vaccine Product
Table 79. Medigen Vaccine Biologics Recent Developments/Updates
Table 80. Shenzhen Neptunus Corporation Information
Table 81. Shenzhen Neptunus Description and Business Overview
Table 82. Shenzhen Neptunus Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. Shenzhen Neptunus Enterovirus Vaccine Product
Table 84. Shenzhen Neptunus Recent Developments/Updates
Table 85. Sinopharm Corporation Information
Table 86. Sinopharm Description and Business Overview
Table 87. Sinopharm Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 88. Sinopharm Enterovirus Vaccine Product
Table 89. Sinopharm Recent Developments/Updates
Table 90. Adimmune Corporation Information
Table 91. Adimmune Description and Business Overview
Table 92. Adimmune Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 93. Adimmune Enterovirus Vaccine Product
Table 94. Adimmune Recent Developments/Updates
Table 95. Intravacc Corporation Information
Table 96. Intravacc Description and Business Overview
Table 97. Intravacc Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 98. Intravacc Enterovirus Vaccine Product
Table 99. Intravacc Recent Developments/Updates
Table 100. Shanghai Zerun Biotechnology Corporation Information
Table 101. Shanghai Zerun Biotechnology Description and Business Overview
Table 102. Shanghai Zerun Biotechnology Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 103. Shanghai Zerun Biotechnology Enterovirus Vaccine Product
Table 104. Shanghai Zerun Biotechnology Recent Developments/Updates
Table 105. Beijing Minhai Biotechnology Corporation Information
Table 106. Beijing Minhai Biotechnology Description and Business Overview
Table 107. Beijing Minhai Biotechnology Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 108. Beijing Minhai Biotechnology Enterovirus Vaccine Product
Table 109. Beijing Minhai Biotechnology Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Enterovirus Vaccine Distributors List
Table 113. Enterovirus Vaccine Customers List
Table 114. Enterovirus Vaccine Market Trends
Table 115. Enterovirus Vaccine Market Drivers
Table 116. Enterovirus Vaccine Market Challenges
Table 117. Enterovirus Vaccine Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Enterovirus Vaccine
Figure 2. Global Enterovirus Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Enterovirus Vaccine Market Share by Type in 2023 & 2030
Figure 4. Coxasckievirus A Product Picture
Figure 5. Coxasckievirus B Product Picture
Figure 6. Human Enterovirus 71 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Enterovirus Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Enterovirus Vaccine Market Share by Application in 2023 & 2030
Figure 10. Hospital
Figure 11. Research Institute
Figure 12. Others
Figure 13. Global Enterovirus Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Enterovirus Vaccine Market Size (2019-2030) & (US$ Million)
Figure 15. Global Enterovirus Vaccine Sales (2019-2030) & (K Doses)
Figure 16. Global Enterovirus Vaccine Average Price (US$/Dose) & (2019-2030)
Figure 17. Enterovirus Vaccine Report Years Considered
Figure 18. Enterovirus Vaccine Sales Share by Manufacturers in 2023
Figure 19. Global Enterovirus Vaccine Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Enterovirus Vaccine Players: Market Share by Revenue in 2023
Figure 21. Enterovirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Enterovirus Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Enterovirus Vaccine Sales Market Share by Country (2019-2030)
Figure 24. North America Enterovirus Vaccine Revenue Market Share by Country (2019-2030)
Figure 25. United States Enterovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Enterovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Enterovirus Vaccine Sales Market Share by Country (2019-2030)
Figure 28. Europe Enterovirus Vaccine Revenue Market Share by Country (2019-2030)
Figure 29. Germany Enterovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Enterovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Enterovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Enterovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Enterovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Enterovirus Vaccine Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Enterovirus Vaccine Revenue Market Share by Region (2019-2030)
Figure 36. China Enterovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Enterovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Enterovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Enterovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Enterovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Enterovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Enterovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Enterovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Enterovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Enterovirus Vaccine Sales Market Share by Country (2019-2030)
Figure 46. Latin America Enterovirus Vaccine Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Enterovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Enterovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Enterovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Enterovirus Vaccine Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Enterovirus Vaccine Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Enterovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Enterovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Enterovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Enterovirus Vaccine by Type (2019-2030)
Figure 56. Global Revenue Market Share of Enterovirus Vaccine by Type (2019-2030)
Figure 57. Global Enterovirus Vaccine Price (US$/Dose) by Type (2019-2030)
Figure 58. Global Sales Market Share of Enterovirus Vaccine by Application (2019-2030)
Figure 59. Global Revenue Market Share of Enterovirus Vaccine by Application (2019-2030)
Figure 60. Global Enterovirus Vaccine Price (US$/Dose) by Application (2019-2030)
Figure 61. Enterovirus Vaccine Value Chain
Figure 62. Enterovirus Vaccine Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
